Literature DB >> 33738545

Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort.

Sung Hye Kong1,2, Jung Hee Kim1,2, Man Young Park3, Sang Wan Kim4,5, Chan Soo Shin1,2.   

Abstract

PURPOSE: Parathyroid carcinoma (PC) is an exceedingly rare endocrine malignancy with a poor prognosis. Due to the rarity, the natural course and prognostic factors of the disease are yet unclear. Therefore, we aimed to identify the incidence, prognosis, and prognostic factors of PC in the nationwide cohort study.
METHODS: The study is a nationwide study using the National Health Insurance Services database in Korea from 2002 to 2017. PC was defined as patients with ICD-10 code of PC and a procedural code for parathyroidectomy.
RESULTS: From 2002 to 2017, 255 patients were diagnosed with PC whose mean age was 53.2 years, and 155 (60.2%) were women. The crude and age-standardized incidence were 10.2 and 6.6/10,000,000 person-year in 2016, rising from 4.1 and 3.8/10,000,000 person-year in 2003 (p < 0.001), respectively. The 5- and 10-year survival rates were 86.5 and 72.9%, respectively. In survival analysis, age over 50 years, thyroidectomy at the initial surgery, and reoperation had increased risk of mortality with HRs of 4.83 (95% CI 1.47-15.90), and 4.21 (95% CI 1.60-11.08), and 1.05 (95% CI 1.02-1.08) in multivariate analysis, respectively.
CONCLUSION: Incidence of PC has been rising over time, similar to the trends in Western countries. The prognostic factors for mortality were old age, parathyroidectomy alone, and recurrence, emphasizing the importance of preoperative suspicion of the disease. The study is clinically meaningful in the first Asian nationwide study to reveal the natural course of PC.

Entities:  

Keywords:  Cohort; Nationwide; Parathyroid carcinoma; Prognosis

Year:  2021        PMID: 33738545     DOI: 10.1007/s00432-021-03576-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  Parathyroid carcinoma: a 43-year outcome and survival analysis.

Authors:  Avital Harari; Avantika Waring; Gustavo Fernandez-Ranvier; Jimmy Hwang; Insoo Suh; Elliot Mitmaker; Wen Shen; Jessica Gosnell; Quan-Yang Duh; Orlo Clark
Journal:  J Clin Endocrinol Metab       Date:  2011-09-21       Impact factor: 5.958

2.  Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring.

Authors:  T Pang; P Stalberg; S Sidhu; M Sywak; M Wilkinson; T S Reeve; L Delbridge
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

3.  Trends in the incidence and treatment of parathyroid cancer in the United States.

Authors:  Peter K Lee; Stephanie L Jarosek; Beth A Virnig; Maria Evasovich; Todd M Tuttle
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

4.  Parathyroid carcinoma: increasing incidence and changing presentation.

Authors:  Sebastian Brown; Christine O'Neill; James Suliburk; Stan Sidhu; Mark Sywak; Anthony Gill; Bruce Robinson; Leigh Delbridge
Journal:  ANZ J Surg       Date:  2011 Jul-Aug       Impact factor: 1.872

5.  Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.

Authors:  Hee Kyung Kim; Young Lyun Oh; Seok-Hyung Kim; Dong Youn Lee; Ho-Cheol Kang; Ji In Lee; Hye Won Jang; Kyu Yeon Hur; Jae Hyeon Kim; Yong Ki Min; Jae Hoon Chung; Sun Wook Kim
Journal:  Head Neck       Date:  2011-06-29       Impact factor: 3.147

6.  Localization and reoperation results for persistent and recurrent parathyroid carcinoma.

Authors:  E Kebebew; C Arici; Q Y Duh; O H Clark
Journal:  Arch Surg       Date:  2001-08

7.  Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  Bone       Date:  2014-12-11       Impact factor: 4.398

Review 8.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

9.  Parathyroid carcinoma: a 22-year experience.

Authors:  Naifa L Busaidy; Camilo Jimenez; Mouhammed Amir Habra; Pamela N Schultz; Adel K El-Naggar; Gary L Clayman; Joshua A Asper; Eduardo M Diaz; Douglas B Evans; Robert F Gagel; Adam Garden; Ana O Hoff; Jeffrey E Lee; William H Morrison; David I Rosenthal; Steven I Sherman; Erich M Sturgis; Steven G Waguespack; Randal S Weber; Kelly Wirfel; Rena Vassilopoulou-Sellin
Journal:  Head Neck       Date:  2004-08       Impact factor: 3.147

10.  The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records.

Authors:  Jong-Kyu Kim; Young Jun Chai; Jung Kee Chung; Ki-Tae Hwang; Seung Chul Heo; Su-Jin Kim; June Young Choi; Ka Hee Yi; Sang Wan Kim; Sung Yong Cho; Kyu Eun Lee
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

View more
  6 in total

Review 1.  Overview of the 2022 WHO Classification of Parathyroid Tumors.

Authors:  Lori A Erickson; Ozgur Mete; C Christofer Juhlin; Aurel Perren; Anthony J Gill
Journal:  Endocr Pathol       Date:  2022-02-17       Impact factor: 3.943

Review 2.  Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.

Authors:  Romans Uljanovs; Stanislavs Sinkarevs; Boriss Strumfs; Liga Vidusa; Kristine Merkurjeva; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

3.  A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study.

Authors:  Mei Tao; Shuyan Luo; Xiaoming Wang; Meng Jia; Xiubo Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

Review 4.  MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives.

Authors:  Marta Wielogórska; Beata Podgórska; Magdalena Niemira; Małgorzata Szelachowska; Adam Krętowski; Katarzyna Siewko
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

5.  A Bibliometric Analysis of the Landscape of Parathyroid Carcinoma Research Based on the PubMed (2000-2021).

Authors:  Chenzhe Feng; Chuwen Tian; Leyi Huang; Haolin Chen; Yeqian Feng; Shi Chang
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

6.  The Clinical Features and Treatment Strategy of Parathyroid Cancer: A Retrospective Analysis.

Authors:  Chen Wang; Kaixue Wen; Li Dai; Shuxin Wen; Yuhao Zhang
Journal:  Biomed Res Int       Date:  2022-09-23       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.